Siddhartha Angadi is a cardiovascular exercise physiologist by training. Angadi’s research has focused on exploring the novel therapeutic utility of exercise in patients with heart failure with preserved ejection fraction, the interaction of exercise and doxorubicin and mitigation strategies for chemotherapy-induced cardiotoxicity in patients with breast cancer and, the diagnostic utility of exercise testing in those with renal transplants and end-stage renal disease.
Angadi's professional activities memberships and fellowships currently include:
- American College of Sports Medicine
- American Heart Association
- American Physiological Society
- Fellow American College of Sports Medicine
Ph.D., Arizona State University, 2012